Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Authors
Keywords
Systemic lupus erythematosus, Clinical disease flare, Clinical disease activity, Cytokines, Biomarkers, Forecasting
Journal
JOURNAL OF AUTOIMMUNITY
Volume 119, Issue -, Pages 102615
Publisher
Elsevier BV
Online
2021-02-23
DOI
10.1016/j.jaut.2021.102615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort
- (2019) Lina Wirestam et al. JOURNAL OF RHEUMATOLOGY
- Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
- (2019) Haiyan Zhou et al. MEDIATORS OF INFLAMMATION
- Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis
- (2019) Z Adhya et al. LUPUS
- Immunologic findings precede rapid lupus flare after transient steroid therapy
- (2019) Rufei Lu et al. Scientific Reports
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
- (2019) Martin Aringer et al. Arthritis & Rheumatology
- Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission
- (2019) Margherita Zen et al. RHEUMATOLOGY
- Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus — a prospective cohort study
- (2018) R J Zhang et al. LUPUS
- Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians
- (2018) Anca D. Askanase et al. ARTHRITIS CARE & RESEARCH
- Emerging areas for therapeutic discovery in SLE
- (2018) Naomi I Maria et al. CURRENT OPINION IN IMMUNOLOGY
- Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus
- (2018) Warren David Raymond et al. CYTOKINE
- Disease course patterns in systemic lupus erythematosus
- (2018) K. Tselios et al. LUPUS
- Pathways of impending disease flare in African-American systemic lupus erythematosus patients
- (2017) Melissa E. Munroe et al. JOURNAL OF AUTOIMMUNITY
- Pathways leading to an immunological disease: systemic lupus erythematosus
- (2017) Olga Zharkova et al. RHEUMATOLOGY
- The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials
- (2017) Joan T. Merrill et al. Arthritis & Rheumatology
- Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features
- (2017) Melissa E. Munroe et al. Arthritis & Rheumatology
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
- (2016) Melissa E Munroe et al. ANNALS OF THE RHEUMATIC DISEASES
- A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
- (2016) Ronald van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Balance between inflammatory and regulatory cytokines in systemic lupus erythematosus
- (2016) Y. Yao et al. GENETICS AND MOLECULAR RESEARCH
- Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
- (2016) Rufei Lu et al. JOURNAL OF AUTOIMMUNITY
- What Causes Lupus Flares?
- (2016) David Fernandez et al. Current Rheumatology Reports
- Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL
- (2016) Caroline Gordon et al. Arthritis & Rheumatology
- Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
- (2016) Nausicaa Clemente et al. Journal of Immunology Research
- RIG-I-like receptors and autoimmune diseases
- (2015) Hiroki Kato et al. CURRENT OPINION IN IMMUNOLOGY
- Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
- (2015) Roba M. Talaat et al. CYTOKINE
- Pathogenesis of Renal Disease in Systemic Lupus Erythematosus—The Role of Autoantibodies and Lymphocytes Subset Abnormalities
- (2015) Desmond Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration
- (2015) Jian Song et al. Cell Reports
- The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort
- (2014) Manuel F Ugarte-Gil et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- The effect of cell death in the initiation of lupus nephritis
- (2014) K. Fenton CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- How should lupus flares be measured? Deconstruction of the Safety of Estrogen in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index flare index
- (2014) Aikaterini Thanou et al. RHEUMATOLOGY
- Proinflammatory Adaptive Cytokine and Shed Tumor Necrosis Factor Receptor Levels Are Elevated Preceding Systemic Lupus Erythematosus Disease Flare
- (2014) Melissa E. Munroe et al. Arthritis & Rheumatology
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Clinical targeting of the TNF and TNFR superfamilies
- (2013) Michael Croft et al. NATURE REVIEWS DRUG DISCOVERY
- Burden of Systemic Lupus Erythematosus on Employment and Work Productivity: Data From a Large Cohort in the Southeastern United States
- (2013) Cristina Drenkard et al. ARTHRITIS CARE & RESEARCH
- Top 10 Things to Know About Lupus Activity Measures
- (2013) Aikaterini Thanou et al. Current Rheumatology Reports
- Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
- (2013) Kichul Ko et al. Frontiers in Immunology
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
- (2012) Hong J. Kan et al. Biomed Research International
- The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus
- (2011) Sokratis A. Apostolidis et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Signaling of c-kit in dendritic cells influences adaptive immunity
- (2010) Prabir Ray et al. Annals of the New York Academy of Sciences
- An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA
- (2010) D. A. Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome
- (2010) A. J. STEIMAN et al. JOURNAL OF RHEUMATOLOGY
- International consensus for a definition of disease flare in lupus
- (2010) N Ruperto et al. LUPUS
- The role of defective clearance of apoptotic cells in systemic autoimmunity
- (2010) Luis E. Muñoz et al. Nature Reviews Rheumatology
- Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment
- (2009) E. Tinazzi et al. INTERNATIONAL IMMUNOLOGY
- Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study
- (2009) M. PETRI et al. JOURNAL OF RHEUMATOLOGY
- Numerical scoring for the Classic BILAG index
- (2009) L. Cresswell et al. RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now